The University of Florida College of Pharmacy’s PGY2 Clinical Pharmacogenomics Residency is a one-year program within the UF Health Precision Medicine Program and the College of Pharmacy for professionals who have completed an ASHP-accredited PGY1 pharmacy residency.
The purpose of the PGY2 Clinical Pharmacogenomics Residency at UF is to build on the Doctor of Pharmacy education and PGY1 pharmacy residency training to develop clinical pharmacists who have the knowledge and skills needed to implement pharmacogenomics into clinical practice.
Program Highlights
MyRx Pharmacogenomic Consultation Service
MyRx pharmacogenomic testing is a service initiated by the UF College of Pharmacy to help people understand how their genes affect drug response. As a resident, you will have an opportunity to interact and support this program.
Educational Opportunities
Education opportunities include a UF College of Pharmacy teaching certificate; a UF College of Pharmacy leadership development series; and access to Graduate Program in Precision Medicine materials.
Pharmacogenomics Consultation Service
Pharmacogenomics specialists, including the resident, are notified when pharmacogenetic results are returned for UF Health patients. Patient-centered recommendations are then provided to the ordering clinician for consideration when making pharmacotherapy decisions.
IGNITE-II
UF is one of five sites involved in the IGNITE-II network. The pharmacogenomics resident is involved with the pragmatic clinical trials and, in turn, gains exposure to a large, multi-site research effort.
Past Graduates in Their Current Roles
Not shown on the map: Hana Al Alshaykh, PharmD, BCPS, Clinical Pharmacogenomics Pharmacy Specialist at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia.
Available Learning Experiences
- Implementation
- Teaching
- Pediatrics
- Gastroenterology
- Research
- Laboratory
- Oncology (somatic and germline)
- Psychiatry
- Leadership
- Informatics
- Cardiology
- And More!
How to Apply
- UF utilizes the Pharmacy Online Residency Centralized Application Service (PhORCAS). All candidates must also register with the ASHP Resident Matching Program.
- Your application must include the following materials, which must be uploaded to PhORCAS:
- Official transcripts from your college of pharmacy
- Curriculum vitae
- One-page letter of intent
- PhORCAS standardized reference form submitted by three references of your choosing
- Participation in Professional Placement Services (PPS) at ASHP Midyear Clinical Meeting is not required, but it is highly encouraged.
The application deadline for 2024-25 has passed.
Program Contacts
Department:
Pharmacotherapy & Translational Research
Emily J Cicali Pharm.D.
Clinical Associate Professor
Email:
emily.cicali@cop.ufl.edu
Department:
Pharmacotherapy & Translational Research
Eda Eken PharmD
Clinical Pharmacogenomics Fellow
Email:
edaeken@ufl.edu
Department:
Pharmacotherapy & Translational Research
Madeline L Norris Pharm.D.
Postdoctoral Associate
Email:
norris.m@ufl.edu